Zn-Fe primary battery-enabled controlled hydrogen release in stomach for improving insulin resistance in obesity-associated type 2 diabetes.
The researchers found that the inflammation of these insulin sensitive tissues was suppressed, and IR was improved in the obesity-associated type 2 diabetic ob/ob mice. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured…
Read Article